Maha Katabi - Net Worth and Insider Trading
Maha Katabi Net Worth
The estimated net worth of Maha Katabi is at least $273 Million dollars as of 2024-05-05. Maha Katabi is the Director of RayzeBio inc and owns about 2,419,528 shares of RayzeBio inc (RYZB) stock worth over $151 Million. Maha Katabi is also the Director of Vera Therapeutics Inc and owns about 2,793,987 shares of Vera Therapeutics Inc (VERA) stock worth over $121 Million. Details can be seen in Maha Katabi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Maha Katabi has not made any transactions after 2024-03-25 and currently still holds the listed stock(s).
Transaction Summary of Maha Katabi
Maha Katabi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maha Katabi owns 7 companies in total, including Inozyme Pharma Inc (INZY) , Akouos Inc (AKUS) , and Bolt Biotherapeutics Inc (BOLT) among others .
Click here to see the complete history of Maha Katabi’s form 4 insider trades.
Insider Ownership Summary of Maha Katabi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2020-07-23 | 10 percent owner |
| AKUS | Akouos Inc | 2020-06-30 | 10 percent owner |
| BOLT | Bolt Biotherapeutics Inc | 2021-02-04 | 10 percent owner |
 | | 2021-06-29 | director & 10 percent owner |
| | 2024-03-25 | director & 10 percent owner |
| | 2022-08-11 | 10 percent owner |
| | 2023-09-19 | director |
Maha Katabi Latest Holdings Summary
Maha Katabi currently owns a total of 2 stocks. Among these stocks, Maha Katabi owns 2,419,528 shares of RayzeBio inc (RYZB) as of September 19, 2023, with a value of $151 Million and a weighting of 55.47%. Maha Katabi also owns 2,793,987 shares of Vera Therapeutics Inc (VERA) as of March 25, 2024, with a value of $121 Million and a weighting of 44.53%.
Latest Holdings of Maha Katabi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RYZB | RayzeBio inc | 2023-09-19 | 2,419,528 | 62.49 | 151,196,305 |
| VERA | Vera Therapeutics Inc | 2024-03-25 | 2,793,987 | 43.44 | 121,370,795 |
Holding Weightings of Maha Katabi
Maha Katabi Form 4 Trading Tracker
According to the SEC Form 4 filings, Maha Katabi has made a total of 1 transactions in RayzeBio inc (RYZB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RayzeBio inc is the acquisition of 472,222 shares on September 19, 2023, which cost Maha Katabi around $9 Million.
According to the SEC Form 4 filings, Maha Katabi has made a total of 2 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Vera Therapeutics Inc is the sale of 834,459 shares on March 25, 2024, which brought Maha Katabi around $34 Million.
Insider Trading History of Maha Katabi
- 1
Maha Katabi Trading Performance
GuruFocus tracks the stock performance after each of Maha Katabi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maha Katabi is 22.31%. GuruFocus also compares Maha Katabi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maha Katabi within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Maha Katabi's insider trading performs compared to the benchmark.
Performance of Maha Katabi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.5 | | | | | |
| Relative Return to S&P 500(%) | 15.21 | | | | | |
Maha Katabi Ownership Network
Maha Katabi Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Maha Katabi is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Maha Katabi made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Maha Katabi Mailing Address
Above is the net worth, insider trading, and ownership report for Maha Katabi. You might contact Maha Katabi via mailing address: Sofinnova Investments, 3000 Sand Hill Road, 4-250, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
